{"transactions":[{"id":728556,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-06-23T20:33:05.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":144400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly installments."}],"balance_after":144400,"derivative":{"exercise_price":2,"expiration_date":"2036-06-18","underlying":"Common Stock","underlying_shares":144400},"source":{"system":"sec-edgar","filing":"0001737287-26-000019","document":"wk-form4_1782246783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728726000019/wk-form4_1782246783.xml","form_type":"4"}},{"id":748753,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:10:04.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":18640,"source":{"system":"sec-edgar","filing":"0001193125-26-260261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260261/ownership.xml","form_type":"4"}},{"id":9229,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2026-06-02T18:11:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":1853.0997,"price":118.72,"value":219999.996384,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":14824.5202,"derivative":{"underlying":"Common Stock","underlying_shares":1853.0997},"source":{"system":"sec-edgar","filing":"0000310158-26-000155","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000031015826000155/form4.xml","form_type":"4"}},{"id":844801,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-14T00:03:03.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":7239,"price":17.02,"value":123207.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards."}],"balance_after":1765,"source":{"system":"sec-edgar","filing":"0001193125-26-106701","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526106701/ownership.xml","form_type":"4"}},{"id":1103408,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-24T01:03:22.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":95400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Mr. Mayo has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Mr. Mayo has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. Mr. Mayo has elected to defer the receipt of Common Stock upon the vesting of her RSUs pursuant to the Companys Non-Employee Director Compensation Policy until the earlier of (i) 30 days following separation from the Board or (ii) a change in control of the Company."}],"balance_after":95400,"derivative":{"underlying":"Common Stock","underlying_shares":95400},"source":{"system":"sec-edgar","filing":"0001737287-25-000073","document":"wk-form4_1750726995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728725000073/wk-form4_1750726995.xml","form_type":"4"}},{"id":23351,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2025-06-03T17:14:10.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":2863.0921,"price":76.84,"value":219999.996964,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":12539.8325,"derivative":{"underlying":"Common Stock","underlying_shares":2863.0921},"source":{"system":"sec-edgar","filing":"0001127602-25-016360","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760225016360/form4.xml","form_type":"4"}},{"id":1213608,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:10.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4792,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037525","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037525/ownership.xml","form_type":"4"}},{"id":1213607,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T00:00:10.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026."}],"balance_after":9004,"source":{"system":"sec-edgar","filing":"0000950170-25-037525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037525/ownership.xml","form_type":"4"}},{"id":1486045,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Stock Option (Right to buy)","published_at":"2024-06-07T21:35:52.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":191082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly installments"}],"balance_after":191082,"derivative":{"exercise_price":2.44,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":191082},"source":{"system":"sec-edgar","filing":"0001593968-24-000841","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000159396824000841/primary_01.xml","form_type":"4"}},{"id":40144,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2024-06-04T18:32:31.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":1752.4295,"price":125.54,"value":219999.99943,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":9379.7044,"derivative":{"underlying":"Common Stock","underlying_shares":1752.4295},"source":{"system":"sec-edgar","filing":"0001127602-24-017574","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760224017574/form4.xml","form_type":"4"}},{"id":1592836,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-07T01:00:20.000Z","date":"2024-03-05","kind":"sale","planned":false,"acquired":false,"shares":3135,"price":122.96,"value":385479.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards."}],"balance_after":6621,"source":{"system":"sec-edgar","filing":"0000950170-24-027497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024027497/ownership.xml","form_type":"4"}},{"id":1599794,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T01:00:35.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":3679,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3679,"derivative":{"exercise_price":128.67,"exercise_date":"2025-03-01","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3679},"source":{"system":"sec-edgar","filing":"0000950170-24-026614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026614/ownership.xml","form_type":"4"}},{"id":1599793,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T01:00:35.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":1846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 1, 2025."}],"balance_after":9756,"source":{"system":"sec-edgar","filing":"0000950170-24-026614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026614/ownership.xml","form_type":"4"}},{"id":1811647,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-09T20:07:07.000Z","date":"2023-08-07","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":4.2855,"value":42855.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.27 to $4.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":25328,"source":{"system":"sec-edgar","filing":"0001593968-23-001153","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000159396823001153/primary_01.xml","form_type":"4"}},{"id":1853759,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T20:57:06.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":116120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly installments"}],"balance_after":116120,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":116120},"source":{"system":"sec-edgar","filing":"0001593968-23-001008","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000159396823001008/primary_01.xml","form_type":"4"}},{"id":55413,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2023-05-31T18:39:48.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":1980.7329,"price":111.07,"value":220000.003203,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."}],"balance_after":7430.3599,"derivative":{"underlying":"Common Stock","underlying_shares":1980.7329},"source":{"system":"sec-edgar","filing":"0001127602-23-017171","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760223017171/form4.xml","form_type":"4"}},{"id":1964283,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:00:22.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3257,"derivative":{"exercise_price":155.99,"exercise_date":"2024-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":3257},"source":{"system":"sec-edgar","filing":"0001209191-23-017394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017394/doc4.xml","form_type":"4"}},{"id":1964282,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T01:00:22.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":1523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024."}],"balance_after":7910,"source":{"system":"sec-edgar","filing":"0001209191-23-017394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017394/doc4.xml","form_type":"4"}},{"id":2109277,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T01:00:55.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":858,"price":109.92,"value":94311.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards."}],"balance_after":6387,"source":{"system":"sec-edgar","filing":"0001209191-22-058283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122058283/doc4.xml","form_type":"4"}},{"id":2208418,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-12T20:48:48.000Z","date":"2022-07-08","kind":"grant","acquired":true,"shares":54487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the stock option shall vest in a series of 36 successive equal installments measured from the date of grant."}],"balance_after":54487,"derivative":{"exercise_price":12.03,"expiration_date":"2032-07-08","underlying":"Common Stock","underlying_shares":54487},"source":{"system":"sec-edgar","filing":"0001737287-22-000053","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728722000053/primary_doc.xml","form_type":"4"}},{"id":2208417,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-12T20:48:48.000Z","date":"2022-07-08","kind":"grant","acquired":true,"shares":35328,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35328,"source":{"system":"sec-edgar","filing":"0001737287-22-000053","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737287/000173728722000053/primary_doc.xml","form_type":"4"}},{"id":65679,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2022-06-01T20:19:28.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":2363.5582,"price":93.08,"value":219999.997256,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":5297.517,"derivative":{"underlying":"Common Stock","underlying_shares":2363.5582},"source":{"system":"sec-edgar","filing":"0001127602-22-016164","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760222016164/form4.xml","form_type":"4"}},{"id":2342983,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-10T01:02:22.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":5077,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5077,"derivative":{"exercise_price":80.42,"exercise_date":"2023-03-07","expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":5077},"source":{"system":"sec-edgar","filing":"0001209191-22-017713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017713/doc4.xml","form_type":"4"}},{"id":2342982,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-10T01:02:22.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":2953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023."}],"balance_after":7245,"source":{"system":"sec-edgar","filing":"0001209191-22-017713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017713/doc4.xml","form_type":"4"}},{"id":2508942,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-18T01:06:35.000Z","date":"2021-11-16","kind":"grant","acquired":true,"shares":8238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three equal annual installments beginning November 16, 2022."}],"balance_after":8238,"derivative":{"exercise_price":83,"exercise_date":"2022-11-16","expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":8238},"source":{"system":"sec-edgar","filing":"0001209191-21-065315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121065315/doc4.xml","form_type":"4"}},{"id":2508941,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T01:06:35.000Z","date":"2021-11-16","kind":"grant","acquired":true,"shares":4292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning November 16, 2022."}],"balance_after":4292,"source":{"system":"sec-edgar","filing":"0001209191-21-065315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121065315/doc4.xml","form_type":"4"}},{"id":86566,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2021-06-02T17:52:40.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":2635.3933,"price":75.89,"value":199999.997537,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include shares acquired in dividend reinvestment transactions."}],"balance_after":2755.2908,"derivative":{"underlying":"Common Stock","underlying_shares":2635.3933},"source":{"system":"sec-edgar","filing":"0001127602-21-018658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221018658/form4.xml","form_type":"4"}},{"id":90995,"issuer":{"id":2807,"kind":"organization","name":"Merck & Co., Inc."},"owners":[{"id":10744,"kind":"person","name":"Mayo Stephen","position":1,"cik":"0001849061","reported_name":"Mayo Stephen","relationship":{"director":true}}],"security":"Phantom Stock","published_at":"2021-03-17T13:47:05.000Z","date":"2021-03-15","kind":"grant","acquired":true,"shares":119.8975,"price":76.23,"value":9139.786425,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation."}],"balance_after":119.8975,"derivative":{"underlying":"Common Stock","underlying_shares":119.8975},"source":{"system":"sec-edgar","filing":"0001127602-21-010907","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/310158/000112760221010907/form4.xml","form_type":"4"}}]}